A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Researchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases ...

Health officials in Europe are reportedly investigating Ozempic and the trendy drug’s possible link to an eye-rotting ...

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Electrical stimulation therapy is being explored as a potential treatment to enhance neuroplasticity and improve visual ...

Two large studies from the University of Southern Denmark (SDU) reveal that the diabetes drug Ozempic may double the risk of ...

The medical team there will do a neurological examination to confirm the diagnose of stroke. This will likely be followed by various imaging tests to determine the cause of stroke and to make a plan ...

Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.

Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...

Because of its complex pathophysiological mechanisms, current treatments for ischemia-reperfusion injury are limited in effectiveness and scope, highlighting the urgent need for new therapies. The ...

Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains unchanged” Ricardo Rubio/Europa Press via Getty Health officials in ...